{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:46Z","timestamp":1707524266323},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.7759\/cureus.13624","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T11:04:20Z","timestamp":1614596660000},"source":"Crossref","is-referenced-by-count":0,"title":["Moyamoya Syndrome Presenting as Refractory Status Epilepticus in a 32-Year-Old Female"],"prefix":"10.7759","author":[{"given":"Ali T","family":"Alhashem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid H","family":"AlSalem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J","family":"Sabihah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dunya","family":"Alfaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott RM","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009, 360:1226-37. 10.1056\/NEJMra0804622","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7198","article-title":"Epidemiology, diagnosis and treatment of moyamoya \u200edisease","volume":"17","author":"Zhang H","year":"2019","unstructured":"Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya \u200edisease. Exp Ther Med. 2019, 17:1977-84. 10.3892\/etm.2019.7198","journal-title":"Exp Ther Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000078894.79866.95","article-title":"Risk of stroke in children: ethnic and gender disparities","volume":"61","author":"Fullerton HJ","year":"2003","unstructured":"Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003, 61:189-94. 10.1212\/01.wnl.0000078894.79866.95","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0303-8467(97)00031-0","article-title":"Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey","volume":"9","author":"Wakai K","year":"1997","unstructured":"Wakai K, Tamakoshi A, Ikezaki K, et al.. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997, 9:1. 10.1016\/s0303-8467(97)00031-0","journal-title":"Clin Neurol Neurosurg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3171\/2014.12.PEDS14563","article-title":"Down syndrome and moyamoya: clinical presentation and surgical management","volume":"16","author":"Ropper AE","year":"2015","unstructured":"Ropper AE, Underberg DL, Robertson RL, Scott RM, Smith ER. Down syndrome and moyamoya: clinical presentation and surgical management. J Neurosurg Pediatr. 2015, 16:58-63. 10.3171\/2014.12.PEDS14563","journal-title":"J Neurosurg Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/amhs.amhs_156_19","article-title":"Moyamoya disease","volume":"7","author":"Menon G","year":"2019","unstructured":"Menon G, Hegde A. Moyamoya disease. Arch Med Health Sci. 2019, 7:224-32. 10.4103\/amhs.amhs_156_19","journal-title":"Arch Med Health Sci"},{"key":"ref7","article-title":"Moyamoya syndrome in children with sickle cell disease: a 10-year single-center experience","volume":"130","author":"Johnson C","year":"2017","unstructured":"Johnson C, Darbari D, Pergami P, Diab Y. Moyamoya syndrome in children with sickle cell disease: a 10-year single-center experience. Blood. 2017, 130:3552.","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199311000-00034","article-title":"Anesthetic management of children with moyamoya syndrome","volume":"77","author":"Soriano SG","year":"1993","unstructured":"Soriano SG, Sethna NF, Scott RM. Anesthetic management of children with moyamoya syndrome. Anesth Analg. 1993, 77:1066-70. 10.1213\/00000539-199311000-00034","journal-title":"Anesth Analg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda S","year":"2008","unstructured":"Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008, 7:1056-66. 10.1016\/S1474-4422(08)70240-0","journal-title":"Lancet Neurol"},{"key":"ref10","article-title":"Post-stroke epilepsy","volume":"78","author":"Rodr\u00edguez Lucci F","year":"2018","unstructured":"Rodr\u00edguez Lucci F, Alet M, Ameriso SF. Post-stroke epilepsy. Medicina. 2018, 78:86-90.","journal-title":"Medicina"},{"key":"ref11","article-title":"Sickle cell disease: a general overview","volume":"62","author":"Schnog JB","year":"2004","unstructured":"Schnog JB, Duits AJ, Muskiet FA, et al.. Sickle cell disease: a general overview. Neth J Med. 2004, 62:364-74.","journal-title":"Neth J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2004.03.100","article-title":"Sickle cell disease pain management following the World Health Organization's protocol","volume":"11","author":"Moussavou A","year":"2004","unstructured":"Moussavou A, Vierin Y, Eloundou-Orima C, Mboussou M, Keita M. Sickle cell disease pain management following the World Health Organization's protocol. Arch Pediatr. 2004, 11:1041-5. 10.1016\/j.arcped.2004.03.100","journal-title":"Arch Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/BF03161089","article-title":"Dose\u2010independent occurrence of seizure with tramadol","volume":"5","author":"Talaie H","year":"2009","unstructured":"Talaie H, Panahandeh R, Fayaznouri MR, Asadi Z, Abdollahi M. Dose\u2010independent occurrence of seizure with tramadol. J Med Toxicol. 2009, 5:63-7. 10.1007\/BF03161089","journal-title":"J Med Toxicol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/1556365050014418","article-title":"Seizures associated with intoxication and abuse of tramadol","volume":"44","author":"Jovanovi\u0107\u2010\u010cupi\u0107 V","year":"2006","unstructured":"Jovanovi\u0107\u2010\u010cupi\u0107 V, Martinovi\u0107 Z, Ne\u0161i\u0107 N. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol. 2006, 44:143-6. 10.1080\/1556365050014418","journal-title":"Clin Toxicol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1331","article-title":"New guideline for tramadol usage following adverse drug reactions reported to the Iranian pharmacovigilance center","volume":"16","author":"Gholami K","year":"2007","unstructured":"Gholami K, Shalviri G, Zarbakhsh A, Daryabari N, Yousefian S. New guideline for tramadol usage following adverse drug reactions reported to the Iranian pharmacovigilance center. Pharmacoepidemiol Drug Saf. 2007, 16:229-37. 10.1002\/pds.1331","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0379-0738(03)00100-2","article-title":"Fatal overdoses of tramadol: is benzodiazepine a risk factor of lethality?","volume":"134","author":"Clarot F","year":"2003","unstructured":"Clarot F, Goulle JP, Vaz E, Proust B. Fatal overdoses of tramadol: is benzodiazepine a risk factor of lethality?. Forensic Sci Int. 2003, 134:57-61. 10.1016\/s0379-0738(03)00100-2","journal-title":"Forensic Sci Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s1353-1131(03)00039-7","article-title":"Tramadol\u2010benzodiazepines and buprenorphine\u2010benzodiazepines: two potentially fatal cocktails?","volume":"10","author":"Clarot F","year":"2003","unstructured":"Clarot F, Proust B, Vaz E, Goulle JP. Tramadol\u2010benzodiazepines and buprenorphine\u2010benzodiazepines: two potentially fatal cocktails?. J Clin Forensic Med. 2003, 10:125-8. 10.1016\/s1353-1131(03)00039-7","journal-title":"J Clin Forensic Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2012.00874.x","article-title":"Recurrent seizures in tramadol intoxication: implications for therapy based on 100 patients","volume":"111","author":"Shadnia S","year":"2012","unstructured":"Shadnia S, Brent J, Mousavi\u2010Fatemi K, Hafezi P, Soltaninejad K. Recurrent seizures in tramadol intoxication: implications for therapy based on 100 patients. Basic Clin Pharmacol Toxicol. 2012, 111:133-6. 10.1111\/j.1742-7843.2012.00874.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.52.245","article-title":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","author":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir. 2012, 52:245-66. 10.2176\/nmc.52.245","journal-title":"Neurol Med Chir"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-004-1118-9","article-title":"Revascularisation surgery for paediatric moyamoya: a review of the literature","volume":"21","author":"Fung LW","year":"2005","unstructured":"Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005, 21:358-64. 10.1007\/s00381-004-1118-9","journal-title":"Childs Nerv Syst"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/51051-moyamoya-syndrome-presenting-as-refractory-status-epilepticus-in-a-32-year-old-female","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:26Z","timestamp":1707507266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/51051-moyamoya-syndrome-presenting-as-refractory-status-epilepticus-in-a-32-year-old-female"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.13624","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}